Aberrant type I and type III collagen gene expression in human breast cancer in vivo
暂无分享,去创建一个
J. Risteli | F. Stenbäck | S. Kauppila | L. Risteli | J Risteli | L Risteli | S Kauppila | F Stenbäck | A Jukkola | A. Jukkola
[1] J. Risteli,et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. , 1993, Clinical chemistry.
[2] L. Liotta,et al. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] M. Al-Adnani,et al. Inappropriate production of collagen and prolyl hydroxylase by human breast cancer cells in vivo. , 1975, British Journal of Cancer.
[4] Gary R. Grotendorst,et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. , 1982, The American journal of pathology.
[5] A. Skubitz,et al. Tumor cell invasion, matrix metalloproteinases, and the dogma. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[6] J. Rosenbloom,et al. Molecular cloning and carboxyl-propeptide analysis of human type III procollagen. , 1984, Nucleic acids research.
[7] J. Risteli,et al. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. , 1996, The American journal of pathology.
[8] T. Hurskainen,et al. Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen alpha 1 (IV) chain genes by cells of early human placenta and gestational endometrium. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[9] R. Timpl,et al. Collagen Fibrillogenesis in Human Skin a , 1985, Annals of the New York Academy of Sciences.
[10] J. Risteli,et al. Immunohistochemical study of type I collagen and type I pN‐collagen in benign and malignant ovarian neoplasms , 1995, Cancer.
[11] J L Kelsey,et al. Breast cancer: magnitude of the problem and descriptive epidemiology. , 1993, Epidemiologic reviews.
[12] P. Sommer,et al. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. , 1997, The American journal of pathology.
[13] J. Foidart,et al. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. , 1993, British Journal of Cancer.
[14] L. Liotta,et al. Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[15] L. Garfinkel,et al. Changing trends: An overview of breast cancer incidence and mortality , 1994, Cancer.
[16] J. Risteli,et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. , 1996, Clinical chemistry.
[17] J. Risteli,et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. , 1988, Clinical chemistry.
[18] M J Bissell,et al. Involvement of extracellular matrix constituents in breast cancer. , 1995, Seminars in cancer biology.
[19] C. Clavel,et al. Detection by in situ hybridization of messenger RNAs of collagen types I and IV in murine mammary cancer , 1989, International journal of cancer.
[20] J. K. Makela,et al. Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain , 1988, Nucleic Acids Res..
[21] R. Stern,et al. The matrix of human breast tumor cells is mitogenic for fibroblasts. , 1984, The American journal of pathology.
[22] K. Kühn. The classical collagens : types I, II and III , 1987 .
[23] J. Risteli,et al. Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP. , 1997, Cancer research.
[24] J. Risteli,et al. Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study , 1993, Cancer.
[25] J. Foekens,et al. Stromal influences on breast cancer cell growth. , 1992, British Journal of Cancer.
[26] M L Tanzer,et al. Cross-Linking of Collagen , 1973, Science.